Alpha-fetoprotein (364-373)

Alpha-fetoprotein (364-373) is a synthetic peptide fragment corresponding to amino acids 364 through 373 of the human alpha-fetoprotein (AFP) sequence. As a segment derived from a well-characterized fetal serum glycoprotein, this peptide is of significant interest in the fields of developmental biology, oncology research, and immunology. Its defined sequence enables precise investigations into the functional domains of AFP, particularly those implicated in molecular recognition, cell signaling pathways, and protein-protein interactions. Researchers utilize this fragment to dissect the structure-function relationships within AFP, advancing understanding of its biological roles and regulatory mechanisms in both normal and pathological contexts.

Epitope mapping: The 364-373 region of alpha-fetoprotein is frequently examined as a potential immunodominant epitope, making the peptide valuable for mapping antibody recognition sites. By employing this defined fragment in immunoassays or binding studies, investigators can identify and characterize the specific regions of AFP targeted by monoclonal or polyclonal antibodies. This application is particularly relevant for the development of highly specific immunodiagnostic reagents, as well as for advancing knowledge of immune surveillance mechanisms in diseases where AFP is a biomarker.

Protein-protein interaction studies: The peptide serves as a model substrate for probing the interaction interfaces between AFP and its binding partners. In biochemical assays, it can be used to evaluate the affinity and specificity of candidate receptors, co-factors, or regulatory proteins that associate with AFP's functional domains. Such studies are instrumental in elucidating the molecular mechanisms underlying AFP-mediated signaling processes, which may include modulation of cell proliferation, differentiation, or apoptosis in developmental and cancer biology research.

Functional analysis of AFP domains: Researchers frequently utilize the 364-373 peptide to investigate the biological activity of discrete AFP regions. By comparing cellular responses or biochemical activities elicited by the peptide versus the full-length protein, it is possible to pinpoint the contribution of this specific segment to AFP's overall function. This approach supports detailed structure-activity relationship studies, facilitating the identification of critical residues responsible for receptor binding, signal transduction, or other bioactive properties.

Peptide-based assay development: The defined sequence and high purity of the AFP (364-373) peptide make it an excellent standard or control in the development and validation of peptide-based assays. Such assays may include enzyme-linked immunosorbent assays (ELISAs), competitive binding formats, or mass spectrometry-based detection platforms. The peptide's use in these contexts ensures reproducibility and accuracy in quantifying AFP-specific antibodies or in screening for molecular interactions relevant to disease biomarker studies.

Peptide synthesis optimization: In the realm of peptide chemistry, the AFP (364-373) fragment is also leveraged as a model substrate for optimizing solid-phase peptide synthesis protocols. Its sequence complexity and physicochemical properties provide a practical test case for evaluating coupling efficiencies, purification strategies, and analytical characterization techniques. This contributes to improved methodologies for preparing research-grade peptides, supporting broader efforts in peptide-based drug discovery, diagnostics, and functional proteomics.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics